BackgroundA-Z Listing of EPARs

EPARs for authorised medicinal products for human use


Please click on a letter to view an indexed list of products:

l
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Name INN Revision Published Additional Information
Abilify INN: aripiprazole Rev. 18 14/10/09  
Abraxane INN: paclitaxel (as paclitaxel albumin) Rev. 3 20/08/09  
Abseamed INN: recombinant human erythropoietin alfa Rev. 7 13/10/09  
Aclasta INN: zoledronic acid Rev. 9 08/07/09  
Acomplia INN: rimonabant Rev. 8 30/01/09

Marketing authorisation withdrawn (30/01/09)
Press Release (23/10/08) and Questions and Answers
Press Release (19/07/07)
Actos INN: pioglitazone Rev. 15 05/10/09  
Actraphane INN: insulin Human (rDNA) Rev. 6 18/02/09  
Actrapid INN: insulin Human (rDNA) Rev. 6 18/02/09  
Adenuric INN: febuxostat Rev. 2 08/09/09  
Adrovance INN: alendronate sodium/colecalciferol Rev. 7 04/09/09  
Advagraf INN: tacrolimus Rev. 7 20/05/09  
Advate INN: octocog alfa Rev. 11 14/07/09  
Aerinaze INN: desloratadine and pseudoephedrine (as sulphate) Rev. 3 08/07/09  
Aerius INN: desloratadine Rev. 20 01/04/09  
Afinitor Orphan Medicinal Product - Click for more information INN: everolimus   02/09/09  
Agenerase INN: amprenavir Rev. 16 02/03/09  
Aldara INN: imiquimod Rev. 15 14/09/09  
Aldurazyme Orphan Medicinal Product - Click for more informationExceptional circumstances - Click for more information INN: laronidase Rev. 8 27/07/09  
Alendronate sodium and colecalciferol, MSD INN: alendronic acid/colecalciferol   17/11/09  
Alimta INN: pemetrexed Rev. 12 09/10/09  
Alisade INN: fluticasone furoate Rev. 1 08/07/09 Previously called: Fluticasone furoate GSK
alli INN: orlistat Rev. 3 06/04/09

Previously called: Orlistat GSK
Press Release (23/10/08)

Allex INN: desloratadine     Marketing authorisation withdrawn (19/05/04)
Aloxi INN: palonosetron Rev. 9 04/08/09  
Altargo INN: retapamulin Rev. 5 28/04/09  
Ambirix Common name: Inactivated Hepatitis A virus HBsAg recombinant purified Rev. 5 15/04/08  
Ammonaps INN: sodium phenylbutyrate Rev. 9 09/11/09  
Angiox INN: bivalirudin Rev. 11 03/09/09  
Apidra INN: insulin glulisine Rev. 13 14/09/09  
Aprovel INN: irbesartan Rev. 23 05/05/09 Press Release (24/04/08)
Q&A (24/04/08)
Aptivus INN: tipranavir Rev. 21 26/10/09  
Aranesp INN: darbepoetin alfa Rev. 22 13/05/09  
Arava INN: leflunomide Rev. 17 16/11/09 Public Statement (12/03/01)
Arcalyst Orphan Medicinal Product - Click for more information INN: rilonacept   12/11/09  
Ariclaim INN: duloxetine Rev. 12 16/07/09  
Arixtra INN: fondaparinux sodium Rev. 15 06/05/09  
Atriance Orphan Medicinal Product - Click for more informationExceptional circumstances - Click for more information INN: nelarabine Rev. 3 16/04/09  
Atripla INN: efavirenz/emtricitabine/tenofovir disoproxil (as fumarate) Rev. 5 13/10/09  
ATryn Exceptional circumstances - Click for more information INN: antithrombin alfa Rev. 6 23/07/09  
Avaglim INN: rosiglitazone/glimepiride Rev. 8 08/10/08 Press Release (24/01/08)
Avamys INN: fluticasone furoate Rev. 1 08/07/09  
Avandamet INN: rosiglitazone/metformin Rev. 13 01/09/09 Press Release (24/01/08)
Avandia INN: rosiglitazone Rev. 19 01/09/09 Press Release (24/01/08)
Avastin INN: bevacizumab Rev. 13 17/09/09  
Avonex INN: interferon beta-la Rev. 13 19/03/09  
Axura INN: memantine Rev. 12 07/09/09  
Azarga INN: brinzolamide/timolol   09/01/09  
Azilect INN: rasagiline Rev. 6 25/09/09  
Azomyr INN: desloratadine Rev. 20 01/04/09  
Azopt INN: brinzolamide Rev. 13 26/01/09